rs140733978
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004304.5(ALK):c.3080C>T(p.Pro1027Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,608,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1027Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_004304.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALK | NM_004304.5 | c.3080C>T | p.Pro1027Leu | missense_variant | 19/29 | ENST00000389048.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALK | ENST00000389048.8 | c.3080C>T | p.Pro1027Leu | missense_variant | 19/29 | 1 | NM_004304.5 | P1 | |
ALK | ENST00000618119.4 | c.1949C>T | p.Pro650Leu | missense_variant | 18/28 | 5 | |||
ALK | ENST00000431873.6 | c.248C>T | p.Pro83Leu | missense_variant, NMD_transcript_variant | 3/14 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000494 AC: 75AN: 151862Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000713 AC: 17AN: 238580Hom.: 0 AF XY: 0.0000855 AC XY: 11AN XY: 128694
GnomAD4 exome AF: 0.0000707 AC: 103AN: 1456808Hom.: 0 Cov.: 32 AF XY: 0.0000691 AC XY: 50AN XY: 724092
GnomAD4 genome ? AF: 0.000493 AC: 75AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.000539 AC XY: 40AN XY: 74248
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | ALK: BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 01, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2023 | See Variant Classification Assertion Criteria. - |
Neuroblastoma, susceptibility to, 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 24, 2024 | - - |
ALK-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 23, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Sep 13, 2021 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at